title: Role of RAAS Inhibition in the Prevention of Cardiovascular Disease.
abstract: The pathogenesis of cardiovascular disease is a complex and dynamic process. The renin-angiotensin-aldosterone system (RAAS) is a potent and powerful mediator in the homeostasis of the cardiovascular and renal systems. RAAS blockade via angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) has been consistently proven to be an effective and safe strategy for the primary and secondary prevention of cardiovascular disease in patients across a wide spectrum of risk. Although the beneficial effects of RAAS blockade may be due to its effects on central and peripheral blood pressure, there are many additional mechanisms to consider that may contribute additional protection. While a combination of ACE inhibitors and ARBs has not yielded significantly positive results, the newer class of direct renin inhibitors (DRIs) may offer a novel and effective strategy for monotherapy as well as in combination.
authors.affiliation: Division of Cardiology, Department of Medicine, NYU Langone Medical Center, Tisch Hospital, 530 First Avenue, Suite 9U, New York, NY, 10016, USA.
authors.forename: Henry A
authors.initials: HA
authors.lastname: Tran
authors.forename: Arthur
authors.initials: A
authors.lastname: Schwartzbard
authors.forename: Howard S
authors.initials: HS
authors.lastname: Weintraub